Pain Pills May Be Future Antibiotics

By interfering with bacterial DNA repair and reproduction, some NSAID pain drugs could find future use as antibiotics. Christopher Intagliata reports 

 

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The pain-relieving effects of drugs like ibuprofen are well known. But ibuprofen and its relatives, known as nonsteroidal anti-inflammatory drugs, may someday have another use—as antibiotics.

Researchers tested three anti-inflammatory drugs: bromfenac, used in eye drops, and carprofen and vedaprofen, both for treating conditions like arthritis in dogs. The investigators found that all three drugs bind to something called the "DNA clamp" in bacteria. That clamp is essential to repairing and replicating DNA. By jamming it, the painkillers can actually kill live E. coli—in a test tube, at least.
 
The findings appear in the journal Chemistry & Biology. [Zhou Yin et al, DNA Replication Is the Target for the Antibacterial Effects of Nonsteroidal Anti-Inflammatory Drugs]
 
Study author Aaron Oakley, of Australia's University of Wollongong, says we still need clinical trials to tell if this trick holds true in humans. But this study is a first step. "I guess it alerts a lot of clinicians to the fact that some of the nonsteroidal anti-inflammatories that they're using may have this off-target effect." And it gives drug developers—like Oakley and his colleagues—a whole new way to attack antibiotic-resistant bacteria.

—Christopher Intagliata

[The above text is a transcript of this podcast.]
 

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe